Cocrystal Pharma, Inc. (NASDAQ:COCP) has a beta value of -0.02 and has seen 1,718,131 shares traded in the recent trading session. The company, currently valued at $79.52 Million, closed the recent trade at $1.5299 per share which meant it lost $0 on the day or -2.87% during that session. The COCP stock price is -92.82% off its 52-week high price of $2.95 and 74.51% above the 52-week low of $0.39. If we look at the company’s 10-day average daily trading volume, we find that it stood at 6.16 Million shares traded. The 3-month trading volume is 3.37 Million shares.
The consensus among analysts is that Cocrystal Pharma, Inc. (COCP) is a Buy stock at the moment, with a recommendation rating of 0. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 1 have rated it as a Hold, with 1 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is $0.
Cocrystal Pharma, Inc. (NASDAQ:COCP) trade information
Despite being -3.18% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Thursday, Jun 25 when the COCP stock price touched $1.7 or saw a rise of 10.29%. Year-to-date, Cocrystal Pharma, Inc. shares have moved 207.77%, while the 5-day performance has seen it change 14.66%. Over the past 30 days, the shares of Cocrystal Pharma, Inc. (NASDAQ:COCP) have changed 58.03%. Short interest in the company has seen 376.04 Million shares shorted with days to cover at 111.58.
Wall Street analysts have a consensus price target for the stock at $5, which means that the shares’ value could jump 226.82% from current levels. The projected low price target is $5 while the price target rests at a high of $5. In that case, then, we find that the current price level is +226.82% off the targeted high while a plunge would see the stock lose 226.82% from current levels.
Cocrystal Pharma, Inc. (COCP) estimates and forecasts
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +0% over the past 5 years. Earnings growth for 2020 is a modest +13.7% while over the next 5 years, the company’s earnings are expected to increase by 0%.